Experimental ocular gene therapy
Age-related macular degeneration (AMD):
In vitro and in vivo studies of viral-delivered antiangiogenic effectors for development of antiangiogenic medicines with the perspective of possible clinical translation of neovessel inhibition treatment based on viral gene transfer technology.
Diabetic retinopathy:
Development of gene medicines to restore imbalanced production of neuroprotective factors related to diabetic retinopathy.
Inherited eye diseases:
Development of gene therapy to treat vision loss due to inherited ocular disease.
Revised: 15 February 2018